Outcome of Repeated Use of Donor Site for Noncultured Epidermal Cellular Grafting in Stable Vitiligo: A Retrospective Study

Table 2

Data on the first and second NCES sessions.

Data	First NCES	Second NCES	value
Median donor-to-recipient ratio (range)	1 : 3 (1 : 1–1 : 20)	1 : 3 (1 : 1–1 : 13.5)	0.661
Mean melanocyte counts ± SD	220.7 (65.5)	242.4 (55.3)	0.440
Donor complication (%)
Keloid	1 (3.3%)	1 (3.3%)	1.000
Prolonged bleeding (>5 minutes)	0	1 (3.3%)	0.317
Recipient (%)			0.540
Scalp	1 (3.3%)	0 (0.0%)
Face	14 (46.7%)	12 (40.0%)
Neck	2 (6.7%)	1 (3.3%)
Chest	0 (0.0%)	1 (3.3%)
Arm(s)	1 (3.3%)	2 (6.7%)
Hand(s)	11 (36.7%)	13 (43.3%)
Thigh(s)	1 (3.3%)	0 (0.0%)
Foot/Feet	0 (0.0%)	1 (3.3%)
Recipient complication (%)
Hypertrophic scar	0 (0.0%)	2 (6.7%)	0.157
Mean repigmentation (%) ± SD	84.2 ± 21.1	82.3 ± 22.1	0.645
Patients achieving repigmentation			0.678
0–24% (poor)	1 (3.3%)	2 (6.7%)
25%–50% (fair)	1 (3.3%)	2 (6.7%)
51%–75% (good)	3 (10.0%)	3 (10.0%)
76%–90% (very good)	16 (53.3%)	12 (40.0%)
91%–100% (excellent)	9 (30%)	11 (36.7%)
Color mismatch (%)	6 (20.0%)	7 (23.3%)	0.706
Pigment loss (%)			1.000
Partial (<50%)	6 (20.0%)	6 (20.0%)
≥50%	1 (3.3%)	1 (3.3%)
No	23 (76.7%)	23 (76.7%)

NCES; autologous noncultured epidermal suspension; SD, standard deviation.